Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Measuring functional proteins in women with polycystic ovary syndrome

Official title: Assessment of the Concentrations of Functional Proteins as Potential Early Markers of Insulin Resistance in Women With Polycystic Ovary Syndrome

Run by Jagiellonian University · NCT06793098 · Data updated 2026-11-12

This study is trying to see if measuring certain proteins in women with polycystic ovary syndrome can help identify those with insulin resistance and improve early diagnosis and treatment options.

More PCOS (Polycystic Ovary Syndrome) trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment100 (estimated)
SponsorJagiellonian University
Academic / other
Locations1 site (Krakow)
StatusRecruiting
StartedJanuary 20, 2025
Main results expectedDecember 1, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 18, 2026
Trial IDNCT06793098 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18-45 years who have been diagnosed with polycystic ovary syndrome.

Probably not a fit

Patients who have had at least one ovary removed or those with treated diabetes or metabolic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to measure and compare the concentrations of functional proteins such as kisspeptin, ghrelin, and zonulin in women with polycystic ovary syndrome (PCOS) who have insulin resistance, those with PCOS without insulin resistance, and women without PCOS. The study seeks to identify potential markers of insulin resistance that could be used for early diagnosis and intervention. By utilizing simpler diagnostic methods like HOMA-IR and fasting insulin measurements, the research aims to enhance understanding of the metabolic disturbances associated with PCOS and their long-term health implications.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and treatment of insulin resistance in women with PCOS, potentially reducing the risk of serious health complications.

How similar studies have gone: While the approach of identifying metabolic markers in PCOS is being explored, this specific methodology and focus on functional proteins is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* women aged 18-45 years

Exclusion Criteria:

* removal of at least one ovary
* treated diabetes of any type
* diagnosed and treated metabolic diseases
* diagnosed and treated autoimmune diseases
* diagnosed and treated autoinflammatory diseases

Where it's running

  • Jagiellonian University
    Krakow, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.